Parecoxib reduces pain and local inflammation factors 3 days after TKA .
Effect of perioperative parecoxib on postoperative pain and local inflammation factors PGE2 and IL-6 for total knee arthroplasty: a randomized, double-blind, placebo-controlled study
Eur J Orthop Surg Traumatol. 2014 Apr;24(3):395-401. doi: 10.1007/s00590-013-1203-4. Epub 2013 Mar 13.100 patients undergoing routine total knee arthroplasty were randomized to receive a parecoxib sodium analgesic regimen or placebo post-surgery, with the primary purpose of evaluating total morphine consumption during the first 24 hours postoperatively. Upon analysis, parecoxib sodium significantly reduced morphine consumption, pain at rest and during movement, and concentration of IL-6 and PGE-2 inflammatory factors, while increasing passive range of motion when compared to placebo during the first three postoperative days.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
